Objective: Metformin was shown to exert an antilipolytic action in adipose tissue (AT) that might mediate beneficial effects on lipid metabolism in diabetic patients. However, during exercise, the inhibition of induced lipolysis in AT would limit the energy substrate supply for working muscle. Thus, the aim of this study was to investigate whether metformin exerts inhibitory effect on exercise-induced lipolysis in subcutaneous adipose tissue (SCAT) (Moro et al., 2007) in humans. Approach: Ten healthy lean men underwent two exercise sessions consisting of 60 min of cycling on bicycle ergometer combined with (a) orally administered metformin and (b) metformin locally administered into SCAT. Microdialysis was used to assess lipolysis in situ in SCAT. Glycerol, metformin and lactate were measured in dialysate and plasma by enzyme colorimetric kits and capillary electrophoresis. Results: Metformin levels increased continuously in plasma during 3 h after oral administration, and peaked after 3.5 h (peak concentration 4 μg/ml). Metformin was detected in dialysate outflowing from SCAT and showed a similar time-course as that in plasma with the peak concentration of 1.3 μg/ml. The lipolytic rate in SCAT (assessed as glycerol release) increased in response to exercise (4.3 ± 0.5-fold vs. basal; p = 0.002) and was not suppressed either by local or oral metformin administration. The lactate levels increased in plasma and in dialysate from SCAT after 30-60 min of exercise (3.6-fold vs. basal; p = 0.015; 2.75-fold vs. basal; p = 0.002, respectively). No effect of metformin on lactate levels in SCAT dialysate or in plasma during exercise was observed. Conclusion: Metformin did not reduce the exercise-induced lipolysis in SCAT. This suggests that metformin administration does not interfere with the lipid mobilization and energy substrate provision during physical activity.

2nd Department of Internal Medicine University Hospital Královské Vinohrady Prague Czechia

Department for the Study of Obesity and Diabetes 3rd Faculty of Medicine Charles University Prague Czechia

Department of Clinical Biochemistry and Sports Medicine Toulouse University Hospital Toulouse France

Department of Hygiene 3rd Faculty of Medicine Charles University Prague Czechia

INSERM UMR1048 Obesity Research Laboratory Institute of Metabolic and Cardiovascular Diseases University of Toulouse Paul Sabatier University Toulouse France

Zobrazit více v PubMed

Ajuwon K. M., Spurlock M. E. (2004). Direct regulation of lipolysis by interleukin-15 in primary pig adipocytes. 287 R608–R611. 10.1152/ajpregu.00192.2004 PubMed DOI

Arner P., Hellstrom L., Wahrenberg H., Bronnegard M. (1990). Beta-adrenoceptor expression in human fat cells from different regions. 86 1595–1600. 10.1172/JCI114880 PubMed DOI PMC

Bourron O., Daval M., Hainault I., Hajduch E., Servant J. M., Gautier J. F., et al. (2010). Biguanides and thiazolidinediones inhibit stimulated lipolysis in human adipocytes through activation of Amp-activated protein kinase. 53 768–778. 10.1007/s00125-009-1639-6 PubMed DOI

Flechtner-Mors M., Ditschuneit H. H., Jenkinson C. P., Alt A., Adler G. (1999). Metformin inhibits catecholamine-stimulated lipolysis in obese, hyperinsulinemic, hypertensive subjects in subcutaneous adipose tissue: an in situ microdialysis study. 16 1000–1006. 10.1046/j.1464-5491.1999.00189.x PubMed DOI

Gaidhu M. P., Ceddia R. B. (2011). The role of adenosine monophosphate kinase in remodeling white adipose tissue metabolism. 39 102–108. 10.1097/JES.0b013e31820ac03e PubMed DOI

Gudat U., Convent G., Heinemann L. (1997). Metformin and exercise: no additive effect on blood lactate levels in health volunteers. 14 138–142. 10.1002/(SICI)1096-9136(199702)14:2<138::AID-DIA311>3.0.CO;2-S PubMed DOI

Hansen M., Palsoe M. K., Helge J. W., Dela F. (2015). The effect of metformin on glucose homeostasis during moderate exercise. 38 293–301. 10.2337/dc14-1480 PubMed DOI

Hotta Y., Nakamura H., Konishi M., Murata Y., Takagi H., Matsumura S., et al. (2009). Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. 150 4625–4633. 10.1210/en.2009-0119 PubMed DOI

Jansson P. A., Smith U., Lonnroth P. (1990). Evidence for lactate production by human adipose tissue in vivo. 33 253–256. 10.1007/BF00404805 PubMed DOI

Johnson S. T., Robert C., Bell G. J., Bell R. C., Lewanczuk R. Z., Boule N. G. (2008). Acute effect of metformin on exercise capacity in active males. 10 747–754. 10.1111/j.1463-1326.2007.00805.x PubMed DOI

Karvonen M. J., Kentala E., Mustala O. (1957). The effects of training on heart rate; a longitudinal study. 35 307–315. PubMed

Kim K. H., Jeong Y. T., Kim S. H., Jung H. S., Park K. S., Lee H. Y., et al. (2013). Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation. 440 76–81. 10.1016/j.bbrc.2013.09.026 PubMed DOI

Kisfalvi K., Eibl G., Sinnett-Smith J., Rozengurt E. (2009). Metformin disrupts crosstalk between G protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth. 69 6539–6545. 10.1158/0008-5472.CAN-09-0418 PubMed DOI PMC

Li L., Han R., Xiao H., Lin C., Wang Y., Liu H., et al. (2014). Metformin sensitizes EGFR-TKI-resistant human lung cancer cells in vitro and in vivo through inhibition of IL-6 signaling and EMT reversal. 20 2714–2726. 10.1158/1078-0432.CCR-13-2613 PubMed DOI

Moro C., Pillard F., De Glisezinski I., Crampes F., Thalamas C., Harant I., et al. (2007). Sex differences in lipolysis-regulating mechanisms in overweight subjects: effect of exercise intensity. 15 2245–2255. 10.1038/oby.2007.267 PubMed DOI

Ortega J. F., Hamouti N., Fernandez-Elias V. E., De Prada M. V., Martinez-Vizcaino V., Mora-Rodriguez R. (2014). Metformin does not attenuate the acute insulin-sensitizing effect of a single bout of exercise in individuals with insulin resistance. 51 749–755. 10.1007/s00592-014-0580-4 PubMed DOI

Robinson A. C., Burke J., Robinson S., Johnston D. G., Elkeles R. S. (1998). The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control. 21 701–705. 10.2337/diacare.21.5.701 PubMed DOI

Siklova-Vitkova M., Polak J., Klimcakova E., Vrzalova J., Hejnova J., Kovacikova M., et al. (2009). Effect of hyperinsulinemia and very-low-calorie diet on interstitial cytokine levels in subcutaneous adipose tissue of obese women. 297 E1154–E1161. 10.1152/ajpendo.00086.2009 PubMed DOI

Stich V., De Glisezinski I., Berlan M., Bulow J., Galitzky J., Harant I., et al. (2000a). Adipose tissue lipolysis is increased during a repeated bout of aerobic exercise. 88 1277–1283. PubMed

Stich V., De Glisezinski I., Crampes F., Hejnova J., Cottet-Emard J. M., Galitzky J., et al. (2000b). Activation of alpha(2)-adrenergic receptors impairs exercise-induced lipolysis in SCAT of obese subjects. 279 R499–R504. PubMed

Tuma P. (2014). Large volume sample stacking for rapid and sensitive determination of antidiabetic drug metformin in human urine and serum by capillary electrophoresis with contactless conductivity detection. 1345 207–211. 10.1016/j.chroma.2014.04.016 PubMed DOI

Verboven K., Hansen D., Moro C., Eijnde B. O., Hoebers N., Knol J., et al. (2016). Attenuated atrial natriuretic peptide-mediated lipolysis in subcutaneous adipocytes of obese type 2 diabetic men. 130 1105–1114. 10.1042/CS20160220 PubMed DOI

Wills B. K., Bryant S. M., Buckley P., Seo B. (2010). Can acute overdose of metformin lead to lactic acidosis? 28 857–861. 10.1016/j.ajem.2009.04.012 PubMed DOI

Zhang T., He J., Xu C., Zu L., Jiang H., Pu S., et al. (2009). Mechanisms of metformin inhibiting lipolytic response to isoproterenol in primary rat adipocytes. 42 57–66. 10.1677/JME-08-0130 PubMed DOI